Medicus Pharma Ltd. Common Stock
MDCX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $2 | $1 | $2 | $1 |
| G&A Expenses | $0 | $5 | $3 | $1 |
| SG&A Expenses | $5 | $5 | $3 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$0 |
| Operating Expenses | $7 | $6 | $5 | $2 |
| Operating Income | -$7 | -$6 | -$5 | -$2 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$9 | -$0 | $0 | $0 |
| Pre-Tax Income | -$16 | -$6 | -$5 | -$2 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$16 | -$6 | -$5 | -$2 |
| % Margin | – | – | – | – |
| EPS | -1.12 | -0.43 | -0.42 | -0.239 |
| % Growth | -160.5% | -2.4% | -75.7% | – |
| EPS Diluted | -1.12 | -0.43 | -0.42 | -0.239 |
| Weighted Avg Shares Out | 19 | 14 | 12 | 10 |
| Weighted Avg Shares Out Dil | 19 | 14 | 12 | 10 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | – | $0 | $0 | $1 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$16 | -$6 | -$5 | -$1 |
| % Margin | – | – | – | – |